Evidence map›Paper›PMID 32825012›Full record

ArticleCancers2020

Interphase Cytogenetic Analysis of G0 Lymphocytes Exposed to α-Particles, C-Ions, and Protons Reveals their Enhanced Effectiveness for Localized Chromosome Shattering-A Critical Risk for Chromothripsis.

Antonio Pantelias, Demetre Zafiropoulos, Roberto Cherubini, Lucia Sarchiapone, Viviana De Nadal, Gabriel E Pantelias, Alexandros G Georgakilas, Georgia I Terzoudi

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Antonio PanteliasLaboratory of Health Physics, Radiobiology & Cytogenetics, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research "Demokritos", 15341 Athens, Greece.ORCID 0000-0001-5013-9519
Demetre ZafiropoulosLegnaro National Laboratories, Italian Institute of Nuclear Physics, 35020 Legnaro (Padova), Italy.
Roberto CherubiniLegnaro National Laboratories, Italian Institute of Nuclear Physics, 35020 Legnaro (Padova), Italy.
Lucia SarchiaponeLegnaro National Laboratories, Italian Institute of Nuclear Physics, 35020 Legnaro (Padova), Italy.
Viviana De NadalLegnaro National Laboratories, Italian Institute of Nuclear Physics, 35020 Legnaro (Padova), Italy.
Gabriel E PanteliasLaboratory of Health Physics, Radiobiology & Cytogenetics, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research "Demokritos", 15341 Athens, Greece.
Alexandros G GeorgakilasDNA Damage Laboratory, Physics Department, School of Mathematical and Physical Sciences, National Technical University of Athens, 15780 Zografou, Greece.ORCID 0000-0002-5971-0010
Georgia I TerzoudiLaboratory of Health Physics, Radiobiology & Cytogenetics, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research "Demokritos", 15341 Athens, Greece.ORCID 0000-0001-6213-5072
Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Legnaro · ITNational Centre of Scientific Research "Demokritos" · GRNational Technical University of Athens · GR

Funding

European Regional Development Fund NSRF 2014-2020, MIS 5002559HFRI - ELIDEK Application: 1193; Fellowship: 469271; Contract: 61505500
6 · The paper itself

Abstract

For precision cancer radiotherapy, high linear energy transfer (LET) particle irradiation offers a substantial advantage over photon-based irradiation. In contrast to the sparse deposition of low-density energy by χ- or γ-rays, particle irradiation causes focal DNA damage through high-density energy deposition along the particle tracks. This is characterized by the formation of multiple damage sites, comprising localized clustered patterns of DNA single- and double-strand breaks as well as base damage. These clustered DNA lesions are key determinants of the enhanced relative biological effectiveness (RBE) of energetic nuclei. However, the search for a fingerprint of particle exposure remains open, while the mechanisms underlying the induction of chromothripsis-like chromosomal rearrangements by high-LET radiation (resembling chromothripsis in tumors) await to be elucidated. In this work, we investigate the transformation of clustered DNA lesions into chromosome fragmentation, as indicated by the induction and post-irradiation repair of chromosomal damage under the dynamics of premature chromosome condensation in G0 human lymphocytes. Specifically, this study provides, for the first time, experimental evidence that particle irradiation induces localized shattering of targeted chromosome domains. Yields of chromosome fragments and shattered domains are compared with those generated by γ-rays; and the RBE values obtained are up to 28.6 for α-particles (92 keV/μm), 10.5 for C-ions (295 keV/μm), and 4.9 for protons (28.5 keV/μm). Furthermore, we test the hypothesis that particle radiation-induced persistent clustered DNA lesions and chromatin decompaction at damage sites evolve into localized chromosome shattering by subsequent chromatin condensation in a single catastrophic event-posing a critical risk for random rejoining, chromothripsis, and carcinogenesis. Consistent with this hypothesis, our results highlight the potential use of shattered chromosome domains as a fingerprint of high-LET exposure, while conforming to the new model we propose for the mechanistic origin of chromothripsis-like rearrangements.

Indexed as

chromatin dynamicschromothripsischromothripsis-like chromosomal rearrangementsC-ionsfingerprint of exposurehigh-LET particle radiationlocalized chromosome shatteringPCC assaypremature chromosome condensation (PCC)protonsradiation oncologyRBE valuesspace radiation protectionα-particles

Identifiers

PMID32825012
PMCPMC7563219
OpenAlexW3055852957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.